UnitedHealth Group Inc (NYSE:UNH) was downgraded by Vetr from a “buy” rating to a “hold” rating in a report issued on Monday. They currently have a $179.00 price target on the healthcare conglomerate’s stock. Vetr‘s target price would indicate a potential upside of 2.46% from the company’s previous close.

A number of other brokerages have also recently weighed in on UNH. Wells Fargo & Co reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, February 21st. Argus reiterated a “buy” rating and set a $170.00 price target on shares of UnitedHealth Group in a research note on Monday, January 23rd. Deutsche Bank AG reiterated a “buy” rating and set a $187.00 price target (up previously from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Oppenheimer Holdings Inc. reiterated an “outperform” rating and set a $187.00 price target (up previously from $186.00) on shares of UnitedHealth Group in a research note on Friday, April 21st. Two research analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $182.78.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group (NYSE:UNH) traded up 1.22% on Monday, hitting $174.70. 3,480,347 shares of the company traded hands. The company has a market capitalization of $168.35 billion, a PE ratio of 22.36 and a beta of 0.68. UnitedHealth Group has a 12 month low of $130.31 and a 12 month high of $176.14. The stock’s 50-day moving average price is $170.57 and its 200-day moving average price is $163.15.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.17 by $0.20. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. The business had revenue of $48.72 billion during the quarter, compared to analysts’ expectations of $48.21 billion. During the same quarter in the prior year, the business posted $1.81 EPS. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group will post $9.79 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://www.americanbankingnews.com/2017/05/22/unitedhealth-group-inc-unh-downgraded-by-vetr-inc-to-hold.html.

In other news, Director Gail R. Wilensky sold 5,310 shares of the stock in a transaction dated Thursday, February 23rd. The shares were sold at an average price of $162.31, for a total value of $861,866.10. Following the completion of the transaction, the director now owns 60,175 shares in the company, valued at approximately $9,767,004.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, April 20th. The shares were sold at an average price of $170.47, for a total transaction of $852,350.00. Following the completion of the transaction, the director now owns 75,735 shares of the company’s stock, valued at approximately $12,910,545.45. The disclosure for this sale can be found here. Insiders sold a total of 40,148 shares of company stock valued at $6,806,849 in the last quarter. Insiders own 1.65% of the company’s stock.

Several institutional investors have recently made changes to their positions in the stock. BlackRock Inc. increased its position in shares of UnitedHealth Group by 2,188.4% in the first quarter. BlackRock Inc. now owns 68,633,762 shares of the healthcare conglomerate’s stock worth $11,256,624,000 after buying an additional 65,634,528 shares in the last quarter. Dodge & Cox bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $1,658,560,000. Norges Bank bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $1,530,177,000. TPG Group Holdings SBS Advisors Inc. bought a new position in shares of UnitedHealth Group during the first quarter worth about $510,530,000. Finally, The Manufacturers Life Insurance Company bought a new position in shares of UnitedHealth Group during the third quarter worth about $391,839,000. Institutional investors and hedge funds own 86.67% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

12 Month Chart for NYSE:UNH

To view Vetr’s full report, visit Vetr’s official website.

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.